{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T21:40:25Z","timestamp":1685396425590},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,2,2]],"date-time":"2010-02-02T00:00:00Z","timestamp":1265068800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1007\/s10549-010-0754-x","type":"journal-article","created":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T08:17:56Z","timestamp":1265012276000},"page":"227-231","source":"Crossref","is-referenced-by-count":9,"title":["The association between ERCC2 Asp312Asn polymorphism and breast cancer risk: a meta-analysis involving 22,766 subjects"],"prefix":"10.1007","volume":"123","author":[{"given":"Lei","family":"Yao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Xin","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia-Jia","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi-Chun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,2,2]]},"reference":[{"key":"754_CR1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","volume":"59","author":"A Jemal","year":"2009","unstructured":"Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225\u2013249","journal-title":"CA Cancer J Clin"},{"key":"754_CR2","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/carcin\/21.4.551","volume":"21","author":"RM Lunn","year":"2000","unstructured":"Lunn RM, Helzlsouer KJ, Parshad R, Umbach DM, Harris EL, Sanford KK, Bell DA (2000) XPD polymorphisms: effects on DNA repair proficiency. Carcinogenesis 21:551\u2013555","journal-title":"Carcinogenesis"},{"key":"754_CR3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1383-5742(02)00009-1","volume":"511","author":"C Bernstein","year":"2002","unstructured":"Bernstein C, Bernstein H, Payne CM, Garewal H (2002) DNA repair\/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis. Mutat Res 511:145\u2013178","journal-title":"Mutat Res"},{"key":"754_CR4","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1101\/gad.10.10.1219","volume":"10","author":"XW Wang","year":"1996","unstructured":"Wang XW, Vermeulen W, Coursen JD, Gibson M, Lupold SE, Forrester K, Xu G, Elmore L, Yeh H, Hoeijmakers JH, Harris CC (1996) The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway. Genes Dev 10:1219\u20131232","journal-title":"Genes Dev"},{"key":"754_CR5","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/aje\/kwj189","volume":"164","author":"M Manuguerra","year":"2006","unstructured":"Manuguerra M, Saletta F, Karagas MR, Berwick M, Veglia F, Vineis P, Matullo G (2006) XRCC3 and XPD\/ERCC2 single nucleotide polymorphisms and the risk of cancer: a HuGE review. Am J Epidemiol 164:297\u2013302","journal-title":"Am J Epidemiol"},{"key":"754_CR6","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1158\/1055-9965.EPI-07-2507","volume":"17","author":"F Wang","year":"2008","unstructured":"Wang F, Chang D, Hu FL, Sui H, Han B, Li DD, Zhao YS (2008) DNA repair gene XPD polymorphisms and cancer risk: a meta-analysis based on 56 case-control studies. Cancer Epidemiol Biomark Prev 17:507\u2013517","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"754_CR7","first-page":"7430","volume":"61","author":"H Seker","year":"2001","unstructured":"Seker H, Butkiewicz D, Bowman ED, Rusin M, Hedayati M, Grossman L, Harris CC (2001) Functional significance of XPD polymorphic variants: attenuated apoptosis in human lymphoblastoid cells with the XPD 312 Asp\/Asp genotype. Cancer Res 61:7430\u20137434","journal-title":"Cancer Res"},{"key":"754_CR8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1023\/A:1019693504183","volume":"75","author":"D Tang","year":"2002","unstructured":"Tang D, Cho S, Rundle A, Chen S, Phillips D, Zhou J, Hsu Y, Schnabel F, Estabrook A, Perera FP (2002) Polymorphisms in the DNA repair enzyme XPD are associated with increased levels of PAH-DNA adducts in a case-control study of breast cancer. Breast Cancer Res Treat 75:159\u2013166","journal-title":"Breast Cancer Res Treat"},{"key":"754_CR9","first-page":"917","volume":"11","author":"A F\u00f6rsti","year":"2004","unstructured":"F\u00f6rsti A, Angelini S, Festa F, Sanyal S, Zhang Z, Grzybowska E, Pamula J, Pekala W, Zientek H, Hemminki K, Kumar R (2004) Single nucleotide polymorphisms in breast cancer. Oncol Rep 11:917\u2013922","journal-title":"Oncol Rep"},{"key":"754_CR10","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1158\/1055-9965.2059.13.12","volume":"13","author":"C Justenhoven","year":"2004","unstructured":"Justenhoven C, Hamann U, Pesch B, Harth V, Rabstein S, Baisch C, Vollmert C, Illig T, Ko YD, Br\u00fcning T, Brauch H (2004) ERCC2 genotypes and a corresponding haplotype are linked with breast cancer risk in a German population. Cancer Epidemiol Biomark Prev 13:2059\u20132064","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"754_CR11","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1093\/carcin\/bgh167","volume":"25","author":"Q Shi","year":"2004","unstructured":"Shi Q, Wang LE, Bondy ML, Brewster A, Singletary SE, Wei Q (2004) Reduced DNA repair of benzo[a]pyrene diol epoxide-induced adducts and common XPD polymorphisms in breast cancer patients. Carcinogenesis 25:1695\u20131700","journal-title":"Carcinogenesis"},{"key":"754_CR12","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1158\/1055-9965.EPI-04-0807","volume":"14","author":"B Kuschel","year":"2005","unstructured":"Kuschel B, Chenevix-Trench G, Spurdle AB, Chen X, Hopper JL, Giles GG, McCredie M, Chang-Claude J, Gregory CS, Day NE, Easton DF, Ponder BA, Dunning AM, Pharoah PD (2005) Common polymorphisms in ERCC2 (Xeroderma pigmentosum D) are not associated with breast cancer risk. Cancer Epidemiol Biomark Prev 14:1828\u20131831","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"754_CR13","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/emm.2005.12","volume":"37","author":"SA Lee","year":"2005","unstructured":"Lee SA, Lee KM, Park WY, Kim B, Nam J, Yoo KY, Noh DY, Ahn SH, Hirvonen A, Kang D (2005) Obesity and genetic polymorphism of ERCC2 and ERCC4 as modifiers of risk of breast cancer. Exp Mol Med 37:86\u201390","journal-title":"Exp Mol Med"},{"key":"754_CR14","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.cccn.2005.03.047","volume":"359","author":"L Zhang","year":"2005","unstructured":"Zhang L, Zhang Z, Yan W (2005) Single nucleotide polymorphisms for DNA repair genes in breast cancer patients. Clin Chim Acta 359:150\u2013155","journal-title":"Clin Chim Acta"},{"key":"754_CR15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10549-005-9151-2","volume":"98","author":"T Debniak","year":"2006","unstructured":"Debniak T, Scott RJ, Huzarski T, Byrski T, Masoj\u0107 B, van de Wetering T, Serrano-Fernandez P, G\u00f3rski B, Cybulski C, Gronwald J, Debniak B, Maleszka R, K\u0142adny J, Bieniek A, Nagay L, Haus O, Grzybowska E, Wandzel P, Niepsuj S, Narod SA, Lubinski J (2006) XPD common variants and their association with melanoma and breast cancer risk. Breast Cancer Res Treat 98:209\u2013215","journal-title":"Breast Cancer Res Treat"},{"key":"754_CR16","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/carcin\/bgi330","volume":"27","author":"LE Mechanic","year":"2006","unstructured":"Mechanic LE, Millikan RC, Player J, de Cotret AR, Winkel S, Worley K, Heard K, Heard K, Tse CK, Keku T (2006) Polymorphisms in nucleotide excision repair genes, smoking and breast cancer in African Americans and whites: a population-based case-control study. Carcinogenesis 27:1377\u20131385","journal-title":"Carcinogenesis"},{"key":"754_CR17","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1158\/1055-9965.EPI-06-0218","volume":"15","author":"J Shen","year":"2006","unstructured":"Shen J, Desai M, Agrawal M, Kennedy DO, Senie RT, Santella RM, Terry MB (2006) Polymorphisms in nucleotide excision repair genes and DNA repair capacity phenotype in sisters discordant for breast cancer. Cancer Epidemiol Biomark Prev 15:1614\u20131619","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"754_CR18","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1158\/1055-9965.EPI-07-0096","volume":"16","author":"KD Crew","year":"2007","unstructured":"Crew KD, Gammon MD, Terry MB, Zhang FF, Zablotska LB, Agrawal M, Shen J, Long CM, Eng SM, Sagiv SK, Teitelbaum SL, Neugut AI, Santella RM (2007) Polymorphisms in nucleotide excision repair genes, polycyclic aromatic hydrocarbon-DNA adducts, and breast cancer risk. Cancer Epidemiol Biomark Prev 16:2033\u20132041","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"754_CR19","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10549-006-9263-3","volume":"101","author":"TJ Jorgensen","year":"2007","unstructured":"Jorgensen TJ, Visvanathan K, Ruczinski I, Thuita L, Hoffman S, Helzlsouer KJ (2007) Breast cancer risk is not associated with polymorphic forms of xeroderma pigmentosum genes in a cohort of women from Washington County, Maryland. Breast Cancer Res Treat 101:65\u201371","journal-title":"Breast Cancer Res Treat"},{"key":"754_CR20","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1476-4598-7-36","volume":"7","author":"D Bernard-Gallon","year":"2008","unstructured":"Bernard-Gallon D, Bosviel R, Delort L, Fontana L, Chamoux A, Rabiau N, Kwiatkowski F, Chalabi N, Satih S, Bignon YJ (2008) DNA repair gene ERCC2 polymorphisms and associations with breast and ovarian cancer risk. Mol Cancer 7:36","journal-title":"Mol Cancer"},{"key":"754_CR21","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1093\/carcin\/bgn193","volume":"29","author":"TR Smith","year":"2008","unstructured":"Smith TR, Levine EA, Freimanis RI, Akman SA, Allen GO, Hoang KN, Liu-Mares W, Hu JJ (2008) Polygenic model of DNA repair genetic polymorphisms in human breast cancer risk. Carcinogenesis 29:2132\u20132138","journal-title":"Carcinogenesis"},{"key":"754_CR22","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10549-009-0390-5","volume":"119","author":"A Jakubowska","year":"2010","unstructured":"Jakubowska A, Gronwald J, Menkiszak J, G\u00f3rski B, Huzarski T, Byrski T, To\u0142oczko-Grabarek A, Gilbert M, Edler L, Zapatka M, Eils R, Lubi\u0144ski J, Scott RJ, Hamann U (2010) BRCA1-associated breast and ovarian cancer risks in Poland: no association with commonly studied polymorphisms. Breast Cancer Res Treat 119:201\u2013211","journal-title":"Breast Cancer Res Treat"},{"key":"754_CR23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2307\/3001666","volume":"10","author":"WG Cochran","year":"1954","unstructured":"Cochran WG (1954) The combination of estimates from different experiments. Biometrics 10:101\u2013129","journal-title":"Biometrics"},{"key":"754_CR24","first-page":"719","volume":"22","author":"N Mantel","year":"1959","unstructured":"Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719\u2013748","journal-title":"J Natl Cancer Inst"},{"key":"754_CR25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177\u2013188","journal-title":"Control Clin Trials"},{"key":"754_CR26","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Smith GD, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629\u2013634","journal-title":"BMJ"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-010-0754-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-010-0754-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-010-0754-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T21:14:38Z","timestamp":1685394878000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-010-0754-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,2]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["754"],"URL":"https:\/\/doi.org\/10.1007\/s10549-010-0754-x","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,2]]}}}